Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer
The DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index.
Abstract
First described over 80 years ago, ataxia-telangiectasia (A-T) was defined as a clinical entity 50 years ago. Although not encountered by most clinicians, it is a paradigm for cancer predisposition and neurodegenerative disorders and has a central role in our understanding of the DNA-damage response, signal transduction and cell-cycle control. The discovery of the protein A-T mutated (ATM) that is deficient in A-T paved the way for rapid progress on understanding how ATM functions with a host of other proteins to protect against genome instability and reduce the risk of cancer and other pathologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 (TP53), which is a major target of the PI3K-related protein kinases (PI3K) ATM and ATR and that plays a pivotal role in DDR 5”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [5]
In the citing paper
“ATM is a defective gene in Ataxia-telangiectasia (A-T), an autosomal recessive disorder with early onset progressive cerebellar ataxia, oculocutaneous telangiectasia, and lymphoid tumor susceptibility [48, 49].”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [48]
Citations
Cites
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466 · cited 1×
“Indeed, chloroquine and other agents that alter chromatin structure can cause partial activation of ATM in the absence of DNA DSB”
BackgroundATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075 · cited 1×
“ATM has multiple substrates — indeed, recent proteomic analysis of phosphoproteins induced by DNA damage suggest that the ATM and ATR network might have as many as 700 substrate”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“This was not surprising, because the stabilization and activation of p53 was defective in A-T cells, and these cells were also characterized by a defective G1–S checkpoint, in which p53 has a central rol”
BackgroundA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Self-citationActivation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
An Oncogene-Induced DNA Damage Model for Cancer Development
Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851 · cited 1×
“DNA breaks per se can also be beneficial in that they activate a DNA-damage response in pre-cancerous cells, thereby establishing a barrier to tumour progressio”
BackgroundATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Research works printed but not linked: 2
- Syllaba, K. & Henner, K. Contribution a l'independence de l'athetose double idiopathique et congenitale. Atteinte familiale, syndrome dystrophique, signe de reseau vasculaire conjonctival, integrite psychique. Rev. Neurol. 1, 541–562 (1926) (in French).
- Digweed, M., Reis, A. & Sperling, K. Nijmegen breakage syndrome: consequences of defective DNA double strand break repair. Bioessays 21, 649–656 (1999). · doi:10.1002/(sici)1521-1878(199908)21:8<649::aid-bies4>3.0.co;2-o
Cited by
Items 601–700 of 898
Omidvar, S., Vahedian, V., Sourani, Z., Yari, D., Asadi, M., Jafari, N., Khodavirdilou, L., Bagherieh, M., Shirzad, M., & Hosseini, V. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155405 · Cited by 9
Genetic Immunodeficiency Diseases
Abrams, M., & Paller, A. S. (2007) · Advances in Dermatology · doi:10.1016/j.yadr.2007.08.001 · Cited by 9
Activation of ATM–Chk2 by 16-dehydropregnenolone induces G1 phase arrest and apoptosis in HeLa cells
Ma, E., Zhao, D., Li, Y., Cao, H., Zhao, Q., Li, J., & Sun, L. (2012) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2012.694874 · Cited by 8
Heidari, M., Soleyman‐Nejad, M., Taskhiri, M. H., Shahpouri, J., Isazadeh, A., Ahangari, R., Mohamadi, A. R., Ebrahimi, M., Karimi, H., Bolhassani, M., et al. (2019) · Current Genomics · doi:10.2174/1389202920666191107153734 · Cited by 9
Milanovic, M., Shao, Z., Estes, V. M., Wang, X. S., Menolfi, D., Lin, X., Lee, B. J., Xu, J., Cupo, O. M., Wang, D., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000967 · Cited by 8
Staudt, D. E., Murray, H. C., Skerrett-Byrne, D. A., Smith, N. D., Jamaluddin, M. F. B., Kahl, R. G. S., Duchatel, R. J., Germon, Z. P., McLachlan, T., Jackson, E. R., et al. (2022) · Clinical Proteomics · doi:10.1186/s12014-022-09385-7 · Cited by 9
Joaquin, A., & Fernández-Capetillo, Ó. (2012) · InTech eBooks · doi:10.5772/50863 · Cited by 15
Radhakrishnan, S. K., Bebb, D. G., & Lees‐Miller, S. P. (2013) · Translational Cancer Research · doi:10.21037/1123 · Cited by 9
The dark side of the oxidative force in angiogenesis
Kerr, B. A., & Byzova, T. V. (2012) · Nature Medicine · doi:10.1038/nm.2881 · Cited by 8
Caspase-2: What do we know today?
Аксенова, В. И., Bylino, O. V., Zhivotovsky, B., & Lavrik, I. N. (2013) · Molecular Biology · doi:10.1134/s0026893313010020 · Cited by 8
Olson, D. J., Bhalla, S., Yang, X. J., Martone, B. K., & Kuzel, T. M. (2016) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2016.03.012 · Cited by 8
Downregulation of ATM Gene and Protein Expression in Canine Mammary Tumors
Raposo-Ferreira, T. M. M., Bueno, R. C., Terra, É. M., Avante, M. L., Tinucci‐Costa, M., Carvalho, M., Cassali, G. D., Linde, S. D., Rogatto, S. R., & Amorim, R. L. (2016) · Veterinary Pathology · doi:10.1177/0300985816643367 · Cited by 10
The Expression of the RUVBL1 Component of the R2TP Complex Correlates with Poor Prognosis in DLBCL
Lone, M. R., Shadang, M., Akhter, Q., Kumar, M., Mallick, S., Gogia, A., Nilima, N., Chauhan, S. S., & Mir, R. A. (2022) · Pathobiology · doi:10.1159/000520723 · Cited by 8
Antitumor Effects of Natural Bioactive Ursolic Acid in Embryonic Cancer Stem Cells
Kang, D. Y., Sp, N., Jang, K., Jo, E. S., Bae, S. W., & Yang, Y. M. (2022) · Journal of Oncology · doi:10.1155/2022/6737248 · Cited by 9
Approach to Neurodegenerative Disease in Children: A Short Review
Mishra, S. (2018) · Progressing Aspects in Pediatrics and Neonatology · doi:10.32474/papn.2018.01.000121 · Cited by 8
ATM in immunobiology: From lymphocyte development to cancer immunotherapy
Lee, J. (2025) · Translational Oncology · doi:10.1016/j.tranon.2024.102268 · Cited by 11
Xu, K., Zhang, Y., Chen, Y., Zhu, X., Li, Y., Lv, L., He, X., Hu, Z., Li, Y., Ye, M., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102355 · Cited by 8
Familial Non-Medullary Thyroid Cancer
Kłubo-Gwieździńska, J., Kushchayeva, Y., Gara, S. K., & Kebebew, E. (2018) · Springer eBooks · doi:10.1007/978-3-319-91725-2_20 · Cited by 8
Zhang, C. L., Chen, X., Zhou, K., Liu, X., Qiao, G., Zhao, Y., Dong, K., Sun, K., & Liu, Z. (2024) · mSystems · doi:10.1128/msystems.01214-23 · Cited by 7
“Ataxia telangiectasia is a rare inherited autosomal recessive genetic disease character ized by growth retardation, premature aging, sterility, neurodegeneration, insulin resistance, immunodeficiency, and cancer predisposition, particularly lymphomas (31, 32).”
BackgroundShah, Y. R., Dahiya, D. S., Tiwari, A., Kumar, H., Gangwani, M. K., Ali, H., Hayat, U., Alsakarneh, S., Singh, S. T., Malik, S., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164706 · Cited by 8
“The ataxia–telangiectasia mutated ( ATM ) gene is a serine/threonine kinase that plays an important role in the repair of DNA double-strand break repair, control, and apoptosis [52,53].”
BackgroundLim, B., Matsui, Y., Jung, S., Djekidel, M. N., Qi, W., Yuan, Z., Wang, X., Yang, X., Connolly, N., Shirinifard, A., et al. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002760 · Cited by 8
Selective Kinase Inhibitors in Cancer
Mortlock, A. A., Wilson, D. M., Kettle, J. G., Goldberg, F. W., & Foote, K. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12391-1 · Cited by 9
DNA Damage Response in Human Stem Cells and Neural Descendants
Beckta, J. M., Adams, B. R., & Valerie, K. C. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6955-5_27 · Cited by 7
Huang, F., Tang, X., Sun, T., Wang, G., Ru, Q., & Zheng, Y. (2021) · Translational Cancer Research · doi:10.21037/tcr-20-698 · Cited by 7
Mechanisms Underlying the Suppression of Chromosome Rearrangements by Ataxia-Telangiectasia Mutated
Yamauchi, M. (2021) · Genes · doi:10.3390/genes12081232 · Cited by 8
Sp, N., Kang, D. Y., Jo, E. S., Lee, J., & Jang, K. (2021) · Cells · doi:10.3390/cells10112847 · Cited by 7
Nie, X., Zheng, M., Gao, L., Hu, Y., Zhuang, Y., Li, X., Zhu, L., Liu, J., & Lin, B. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108726 · Cited by 7
ATM deficiency aggravates the progression of liver fibrosis induced by carbon tetrachloride in mice
Li, M., Yang, Z., Song, Z., Bo, C., Wang, S., & Jia, Q. (2022) · Toxicology · doi:10.1016/j.tox.2022.153397 · Cited by 9
ATMIN: A New Tumor Suppressor in Developing B Cells
Liu, X., & Zha, S. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.002 · Cited by 7
Functional analysis—Make or break for cancer predictability
Deniz, M., Holzmann, K., & Wiesmüller, L. (2013) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2013.03.009 · Cited by 7
Recent advances in chronic lymphocytic leukemia
Vyas, N. M., & Hassan, A. F. (2012) · Indian Journal of Cancer · doi:10.4103/0019-509x.98940 · Cited by 7
Haploinsufficiency of Bcl11b suppresses the progression of ATM-deficient T cell lymphomas
Pinkney, K. A., Jiang, W., Lee, B. J., Loredan, D. G., Li, C., Bhagat, G., & Zha, S. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0191-8 · Cited by 9
Mouse Models of Inherited Cancer Syndromes
Jahid, S., & Lipkin, S. M. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.011 · Cited by 7
Redon, C. E., Dickey, J. S., Nakamura, A., Martin, O. A., & Bonner, W. M. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8044-1_1 · Cited by 11
Sordet, O., & Solier, S. (2011) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-0323-4_19 · Cited by 8
Öğülür, İ., Ertuzun, T., Kolukısa, B., Demirkol, Y. K., Uyar, E., Kıykım, A. A., Başer, D., Yeşil, G., Aktürk, H., Somer, A., et al. (2020) · Pediatric Allergy and Immunology · doi:10.1111/pai.13387 · Cited by 7
Granzotto, A., Bencokova, Z., Vogin, G., Devic, C., Joubert, A., Balosso, J., & Foray, N. (2011) · InTech eBooks · doi:10.5772/19475 · Cited by 16
“A bad wound may heal, but a bad name can kill”—lessons learned from “hyper-IgM syndrome”
Hennig, C., Happle, C., & Hansen, G. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.07.041 · Cited by 7
Liu, S., Tao, Y., Chen, X., & Cao, Y. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1435-5 · Cited by 7
Targeting DNA damage response kinases in cancer therapy
Gottifredi, V. (2020) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2020.111725 · Cited by 7
Ding, M., Qing, X., Zhang, G., Baade‐Büttner, C., Gruber, R., Lu, H., Ferguson, D. O., Geis, C., Wang, Z., & Zhou, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.786199 · Cited by 7
TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q
Garding, A., Bhattacharya, N., Haebe, S., Muller, F., Weichenhan, D., Idler, I. S., Ickstadt, K., Stilgenbauer, S., & Mertens, D. (2012) · Haematologica · doi:10.3324/haematol.2012.070623 · Cited by 6
Pang, Y., Xu, Y., Li, H., Li, Y., Zhao, Y., Jiang, R., Shen, L., Zhou, J., Wang, X., & Liu, Q. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.01.004 · Cited by 7
Suzuki, K., Takahashi, M., Oka, Y., Yamauchi, M., Suzuki, M., & Yamashita, S. (2010) · Genome Integrity · doi:10.1186/2041-9414-1-4 · Cited by 7
Bhatt, N., Ghosh, R., Roy, S., Gao, Y., Armanios, M. Y., Cheng, L., & Franco, S. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.08.006 · Cited by 6
Human Diseases Associated With Genome Instability
Feltes, B. C., Poloni, J. D. F., Miyamoto, K. N., & Bonatto, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803309-8.00026-4 · Cited by 7
Gu, Y., Shi, J., Qiu, S., Qiao, Y., Zhang, X., Cheng, Y., & Liu, Y. (2018) · BMC Cancer · doi:10.1186/s12885-018-4941-1 · Cited by 6
Cancer diagnosis and immunotherapy in the age of CRISPR
Cook, P. J., & Ventura, A. (2018) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22702 · Cited by 6
Emerging Subtypes and New Treatments for Castration-Resistant Prostate Cancer
Carneiro, B. A., Lotan, T. L., Souza, A. O., & Aggarwal, R. R. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_100025 · Cited by 6
Wölke, S., Donath, H., Bakhtiar, S., Trischler, J., Schubert, R., & Zielen, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108491 · Cited by 6
Roberts, N. J., & Klein, A. P. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_78 · Cited by 6
Saberi‐Karimian, M., Beyraghi‐Tousi, M., Jamialahmadi, T., & Sahebkar, A. (2022) · Clinical Case Reports · doi:10.1002/ccr3.5895 · Cited by 6
Statistical Analysis of ATM-Dependent Signaling in Quantitative Mass Spectrometry Phosphoproteomics
Waardenberg, A. J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6955-5_17 · Cited by 6
Seol, M. Y., Choi, S. H., & Yoon, H. I. (2025) · Journal of Neuro-Oncology · doi:10.1007/s11060-025-05128-4 · Cited by 7
Torices, L., Nunes‐Xavier, C. E., & Pulido, R. (2025) · IUBMB Life · doi:10.1002/iub.70018 · Cited by 6
Vogel, S., & Herzinger, T. (2013) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/phpp.12071 · Cited by 5
DNA Double-Strand Break Repair by Non-homologous End Joining and Its Clinical Relevance
Weinfeld, M., & Lees‐Miller, S. P. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-384999-1.10008-3 · Cited by 6
Subversion of cellular stress responses by poxviruses
Leão, T. L., & da Fonseca, F. G. (2014) · World Journal of Clinical Infectious Diseases · doi:10.5495/wjcid.v4.i4.27 · Cited by 6
Second-line therapy in advanced upper gastrointestinal cancers: current status and new prospects
Saletti, P., & Zaniboni, A. (2018) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2018.01.12 · Cited by 6
Shimazaki, H., Kobayashi, J., Sugaya, R., Nakano, I., & Fujimoto, S. (2020) · Journal of Integrative Neuroscience · doi:10.31083/j.jin.2020.01.1239 · Cited by 5
Hypoxia and the DNA Damage Response
Olcina, M. M., & Hammond, E. M. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9167-5_2 · Cited by 8
Reprint of “Functional overlaps between XLF and the ATM-dependent DNA double strand break response”
Kumar, V., Alt, F. W., & Oksenych, V. (2014) · DNA repair · doi:10.1016/j.dnarep.2014.04.004 · Cited by 6
The activation mechanisms of master kinases in the DNA damage response
Xiao, J., Rao, Q., & Xu, Y. (2021) · Genome Instability & Disease · doi:10.1007/s42764-021-00045-y · Cited by 5
Ganapathy, A. K., Diaz, E. J., Coleman, J. T., & Mackey, K. A. (2021) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2021.09.007 · Cited by 5
Therapeutic targets and investigated treatments for Ataxia-Telangiectasia
Lavin, M. F., Yeo, A. J., Kijas, A. W., Wolvetang, E. J., Sly, P. D., Wainwright, C. E., & Sinclair, K. (2016) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2016.1254618 · Cited by 7
Self-citationNueva mutación en el gen ATM en paciente con ataxis telangiectasia: Caso clínico
Ruiz-Botero, F., & Rodríguez-Guerrero, J. T. (2017) · Revista chilena de pediatría · doi:10.4067/s0370-41062017000400013 · Cited by 5
A novel mutation in ATM gene in a Saudi female with ataxia telangiectasia
Algahtani, H. A., Shirah, B. H., Algahtani, R., Al-Qahtani, M. H., Abdulkareem, A. A., & Naseer, M. I. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1736582 · Cited by 5
Targeting DNA Repair and Chromatin Crosstalk in Cancer Therapy
Johnson, D. P., Chandrasekharan, M. B., Dutreix, M., & Bhaskara, S. (2021) · Cancers · doi:10.3390/cancers13030381 · Cited by 6
Kuo, C., Shieh, C., Cai, F., & Ann, D. K. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2011.00061 · Cited by 8
Suetomi, K., Mochizuki, M., Suzuki, S., Yamamoto, H., & Yamamoto, K. (2010) · Genes & Genetic Systems · doi:10.1266/ggs.85.1 · Cited by 5
A New Player in the Development of TRAIL Based Therapies for Hepatocarcinoma Treatment: ATM Kinase
Stagni, V., Santini, S., & Barilà, D. (2012) · Cancers · doi:10.3390/cancers4020354 · Cited by 5
Kinase Inhibitors with Redox and Anti-inflammatory Activities
Ivanovska, N., Saso, L., & Dimitrova, P. A. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150220115838 · Cited by 6
Suzuki, K., Yamauchi, M., & Yamashita, S. (2011) · Radiation Protection Dosimetry · doi:10.1093/rpd/ncq533 · Cited by 5
Wald-Altman, S., Pichinuk, E., Kakhlon, O., & Weil, M. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027938 · Cited by 7
Screening patients at high risk for pancreatic cancer—Is it time for a paradigm shift?
Lo, W. M., Morris, M. C., Ahmad, S. A., & Patel, S. H. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25616 · Cited by 7
Donath, H., Wölke, S., Knop, V., Heß, U., Duecker, R. P., Trischler, J., Poynard, T., Schubert, R., & Zielen, S. (2023) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2023/2877350 · Cited by 5
Mosaic forms of ataxia telangiectasia
Kuranova, M. L., Pleskach, N. M., Ledashcheva, T. A., Mikhelson, V. M., & Im, S. (2015) · Cell and Tissue Biology · doi:10.1134/s1990519x15010058 · Cited by 6
“With such serious violations of the cellular response to DNA damage as in AT, there is a change of chroma tin conformation (Shiloh, 2003; Lavin, 2008).”
Xing, X., Liu, C. X., Tang, S., Li, D., Chen, L., Pang, Y., Wang, Q., Zhang, B., Zeng, X., Chen, W. L., et al. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.02.002 · Cited by 4
Mitochondrial dysfunction in a novel form of autosomal recessive ataxia
Murad, N. A. A., Cullen, J. K., McKenzie, M., Ryan, M. T., Thorburn, D. R., Gueven, N., Kobayashi, J., Birrell, G. W., Yang, J., Dörk, T., et al. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.11.006 · Cited by 4
“T like disorder (A–TLD) and spinocerebellar ataxia with axonal neuropathy (SCAN1) are also associated with an abnormal response to DNA damage (Lavin, 2008).”
Self-citationTargeting ATM for Cancer Therapy: Prospects for Drugging ATM
Hickson, I., Pike, K. G., & Durant, S. T. (2018) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-75836-7_8 · Cited by 4
Wilson, P. F., & Bedford, J. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5897-7.00001-9 · Cited by 5
Sun, J. K., Wong, G. C., & Chow, H. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15881 · Cited by 5
Deciphering the interstrand crosslink DNA repair network expressed by Trypanosoma brucei
Dattani, A., & Wilkinson, S. R. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.04.009 · Cited by 4
Tyrosyl-DNA Phosphodiesterase I a critical survival factor for neuronal development and homeostasis
van Waardenburg, R. C. A. M. (2016) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2016/5.1048 · Cited by 4
Lavin, M. F., & Yeo, A. J. (2021) · Neuron · doi:10.1016/j.neuron.2021.11.019 · Cited by 5
Self-citationRoles of MicroRNA in DNA Damage and Repair
Chen, X., & Che, T. (2011) · InTech eBooks · doi:10.5772/21740 · Cited by 5
Premature aging syndrome in ataxia telangiectasia patients
Polubotko, E. A., Smirnova, N. V., Pleskach, N. M., Mikhelson, V. M., & Im, S. (2009) · Cell and Tissue Biology · doi:10.1134/s1990519x09050125 · Cited by 4
“Reduced repair potency is associated with increased radiosensitivity and an inability to block the cell cycle after irradiation (Lavin, 2008).”
InfluentialInmunodeficiencia con ataxia telangiectasia. Reporte de un caso
Grau, I. M., & Díaz, J. V. (2009) · Inmunología · doi:10.1016/s0213-9626(09)70023-x · Cited by 4
Oka, Y., Yamauchi, M., Suzuki, M., Yamashita, S., & Suzuki, K. (2011) · Journal of Radiation Research · doi:10.1269/jrr.10164 · Cited by 4
Roberts, N. J., & Klein, A. P. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_78-1 · Cited by 4
Distefano, A., Pappalardo, M., Turco, R., Grasso, G., & Guccione, S. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118621 · Cited by 3
Dematteis, G., Lecchi, G., Boni, G., Pendin, D., Distasi, C., Grilli, M., Lim, D., Fresu, L. G., & Talmon, M. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02485-x · Cited by 3
“Ataxia-telangiectasia (A-T) is a neurodegenerative disorder resulting from the loss of function of ataxia telangiectasia mutated (ATM) protein [1 – 3], a serine/threonine kinase involved in the DNA-damage signalling [4].”
Molecular Bases of Ataxia Telangiectasia: One Kinase Multiple Functions
Stagni, V., Santini, S., & Baril, D. (2013) · InTech eBooks · doi:10.5772/54045 · Cited by 3
Schanz, S. (2014) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000196 · Cited by 3
Lou, C., Yokoyama, S., Abdelhamed, S., Saiki, I., & Hayakawa, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.4554 · Cited by 3
Lim, Y. C. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6955-5_6 · Cited by 4
Association of germline ATM mutations and survival in pancreatic cancer
Gower, A., Gresham, G. K., Spector, K., Haladjian, N., Lee, J., Mehta, S., Osipov, A., & Hendifar, A. E. (2021) · Annals of Pancreatic Cancer · doi:10.21037/apc-20-38 · Cited by 5
Prognostic significance of ATM mutations in chronic lymphocytic leukemia: A meta-analysis
Vaji, F. B., Nasr, A. B., Rezvani, A., Ayatollahi, H., Goudarzi, S., Lavasani, S., & Bagheri, R. (2021) · Leukemia Research · doi:10.1016/j.leukres.2021.106729 · Cited by 3
Phenotypic Analysis of ATM Protein Kinase in DNA Double-Strand Break Formation and Repair
Mian, E., & Wiesmüller, L. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6955-5_23 · Cited by 3
Arts, H. H., Lynch, L., Grafodatskaya, D., Eng, B., Malloy, L., Duck, J., White, R., Woodside, C., Bell, K., Zbuk, K. M., et al. (2019) · Cancer Genetics · doi:10.1016/j.cancergen.2019.10.003 · Cited by 3
Metadata
- Authors
- Lavin, M. F.
- Affiliations
- QIMR Berghofer Medical Research Institute (AU)
- Corresponding author
- Lavin, Martin F.
- ORCID
- Lavin, Martin F.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2008-10
- Volume
- 9
- Issue
- 10
- Pages
- 759-769
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2139777089
- Cited by
- 901
- References
- 126
- Citations by year
- 2026: 15 · 2025: 16 · 2024: 17 · 2023: 19 · 2022: 36 · 2021: 43 · 2020: 36 · 2019: 42 · 2018: 26 · 2017: 54 · 2016: 50 · 2015: 45 · 2014: 63 · 2013: 76 · 2012: 90
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-12-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- ataxia telangiectasia, ATM protein, DNA damage response, genomic instability, cancer susceptibility, neurodegenerative diseases, signal transduction, cell cycle regulation
- MeSH terms
- Animals, Ataxia Telangiectasia, DNA Damage, DNA Repair, DNA-Binding Proteins, Humans, Insulin Resistance, Models, Biological, Mutation, Neoplasms, Nerve Degeneration, Protein Processing, Post-Translational, Signal Transduction, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Genetic Predisposition to Disease, Metabolic Syndrome, Tumor Suppressor Proteins, Mice, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.